Publications by authors named "Cheryl J Fitzer-Attas"

9Publications

PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.

Mov Disord 2020 04 22;35(4):606-615. Epub 2020 Jan 22.

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27963DOI Listing
April 2020

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Mov Disord 2016 10;31(10):1489-1496

Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26724DOI Listing
October 2016

Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.

Lancet Neurol 2015 Feb 8;14(2):145-52. Epub 2014 Dec 8.

Clinical Investigation Center CIC1436, Departments of Clinical Pharmacology and Neurosciences, INSERM and University Hospital of Toulouse, Faculty of Medicine, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(14)70288-1DOI Listing
February 2015

Long-term efficacy of rasagiline in early Parkinson's disease.

Int J Neurosci 2010 Jun;120(6):404-8

Department of Neurology, Keck/University of Southern California School of Medicine, Los Angeles, California 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207451003778744DOI Listing
June 2010

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Mov Disord 2009 Mar;24(4):564-73

Parkinsons's Disease and Movement Disorders Center, University of South Florida, 5 Tampa General Circle, Tampa, FL 33606, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.22402DOI Listing
March 2009